Headlines,Tandem Diabetes Care shares saw a significant rise after a crucial EU approval for its insulin delivery system.,The ...

Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Weight loss drugs have gained attention as a tool to help combat obesity, but understanding how they work, who they’re for, ...

In this interview business solutions features, how IoHT is enabling personalized care, improving mental health, patient ...

Consuming more ultraprocessed foods could mean a greater risk for type 2 diabetes, according to new research. Experts share ...

Diabetes, a widespread condition affecting approximately 13% of American adults, is often accompanied by complications such ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

A recent study from Western Sydney University has shown that a simple change in how healthcare providers manage type 2 ...

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...